Inspire Medical Systems, Inc. (INSP) financial statements (2021 and earlier)

Company profile

Business Address 5500 WAYZATA BLVD
GOLDEN VALLEY, MN 55416
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments234235243136149152159
Cash and cash equivalents19117921176234851
Short-term investments44563160127104107
Receivables2521101113119
Inventory, net of allowances, customer advances and progress billings89107654
Inventory89107654
Prepaid expense2241236
Total current assets:270267267155171170177
Noncurrent Assets
Operating lease, right-of-use asset600    
Property, plant and equipment5433332
Long-term investments and receivables   66106
Long-term investments   66106
Other noncurrent assets0   0  
Other undisclosed noncurrent assets 001100
Total noncurrent assets:11541011138
TOTAL ASSETS:281272271166181183186
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2118131417139
Accounts payable7756453
Accrued liabilities1411881286
Total current liabilities:2118131417139
Noncurrent Liabilities
Long-term debt and lease obligation31252525252424
Long-term debt, excluding current maturities25252525252424
Operating lease, liability6      
Liabilities, other than long-term debt00000  
Other liabilities00000  
Total noncurrent liabilities:31252525252424
Total liabilities:51433838413733
Stockholders' equity
Stockholders' equity attributable to parent230229234127140146152
Common stock0000000
Additional paid in capital467459453323320317315
Accumulated other comprehensive income0000000
Accumulated deficit(237)(230)(219)(196)(180)(171)(163)
Total stockholders' equity:230229234127140146152
TOTAL LIABILITIES AND EQUITY:281272271166181183186

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues46361221272118
Cost of revenue(7)(5)(2)(3)(4)(3)(3)
Cost of goods and services sold(7)(5)(2)(3) (3)(3)
Gross profit:39311018231715
Operating expenses(46)(41)(33)(34)(32)(26)(23)
Operating loss:(7)(10)(23)(16)(9)(9)(8)
Nonoperating income (expense)(0)(0)(0)0001
Investment income, nonoperating0001111
Other nonoperating income0000000
Interest and debt expense(1)(1)(1)(1)(1)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(8)(11)(24)(17)(10)(9)(8)
Other undisclosed income from continuing operations before income taxes1111111
Loss from continuing operations before income taxes:(7)(10)(23)(16)(9)(8)(8)
Income tax expense(0)(0)     
Other undisclosed loss from continuing operations    (0)  
Net loss available to common stockholders, diluted:(7)(10)(23)(16)(9)(8)(8)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(7)(10)(23)(16)(9)(8)(8)
Other undisclosed comprehensive loss    (0)  
Comprehensive loss:(7)(10)(23)(16)(9)(8)(8)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)(0)0000
Comprehensive loss, net of tax, attributable to parent:(8)(10)(23)(16)(9)(8)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: